Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine.  Uscher-Pines L, Sousa J, Raja P, Mehrotra A, Barnett M, Huskamp HA.  J Subst Abuse Treat. 2020 Nov;118:108124. doi: 10.1016/j.jsa…

Pandemic waivers made it easier to get treatment for opioid addiction. That could all go away next month.  Waivers on telehealth restrictions have opened the door to a previously unattainable type of care for people with opioid use disorder. W…

Russland. Russian Drug Users Describe Life and Trends During the Pandemic Drug use is globally interconnected. Just thinking of the routes illegal drugs take up to the point of consumption—from being grown or synthesized in producer countries, refi…

Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19 Davis CS, Samuels EA.  [published online ahead of print, 2020 Aug 15]. Int J Drug Policy. 2020;102905. doi:10.1016/j.drugpo.2020.10290…

Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report.  Harris M, Johnson S, Mackin S, Saitz R, Walley AY, Taylor JL.  J Addict Med. 2020;14(4):e136-e138. doi:10.1097/ADM.0000000000000682 https://www.ncbi.nlm.nih.gov/pmc…

Opioid substitution therapy with buprenorphine-naloxone during COVID-19 outbreak in India: Sharing our experience and interim standard operating procedure.  Basu D, Ghosh A, Subodh BN, Mattoo SK.  Indian J Psychiatry. 2020;62(3):322-326…